Tenet Healthcare diskutieren
Tenet Healthcare
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /
169,00 €
-0,59 %
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Citigroup Inc. from $139.00 to $171.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $156.00 to $171.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $145.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $156.00 to $173.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $180.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $168.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $168.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $200.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at KeyCorp to a "strong-buy" rating.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Truist Financial Co. from $170.00 to $180.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $175.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $197.00 to $217.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $190.00 price target on the stock, up previously from $180.00.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $174.00 to $183.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $173.00 to $196.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Cantor Fitzgerald from $168.00 to $177.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $195.00 to $205.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $171.00 to $190.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $195.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $175.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Neueste Beiträge
TD_Cowen in Servicenow Inc. diskutieren, ServiceNow Inc.